Unichem Laboratories Limited (UNICHEMLAB) Financial History

Name: Unichem Laboratories Limited (UNICHEMLAB) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Unichem Laboratories Limited (UNICHEMLAB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 2,780 employees. Its market capitalization is roughly ₹38 billion. In the fiscal year ended 2026-03-31, UNICHEMLAB reported ₹21.6B in revenue and ₹2.5B in net income.

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally.

Interactive charts & full statements →

UNICHEMLAB Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹21.6B	₹20.6B	₹17.4B	₹13.0B	—
Gross Profit	₹10.0B	₹10.7B	₹8.7B	₹6.3B	—
Operating Income (EBIT)	₹636M	₹1.4B	(₹363M)	(₹1.6B)	—
Net Income	₹2.5B	₹1.4B	(₹938M)	(₹2.0B)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UNICHEMLAB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹6.3B	₹5.8B	₹5.2B	₹5.8B	₹5.3B
Gross Profit	₹3.4B	₹3.1B	₹2.8B	₹3.1B	₹2.8B
Operating Income (EBIT)	₹400M	₹171M	₹135M	₹347M	(₹93M)
Net Income	₹415M	₹109M	₹2.6B	(₹119M)	(₹105M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UNICHEMLAB Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹4M)	(₹3M)	(₹2M)	(₹282M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UNICHEMLAB Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹37.4B	₹35.7B	₹32.7B	₹31.9B	—
Total Liabilities	₹10.2B	₹11.2B	₹8.4B	₹7.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UNICHEMLAB viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

RPGLIFE · RPG Life Sciences Limited — ₹46 billion
2196 · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — HK$46 billion
GUFICBIO · Gufic Biosciences Limited — ₹44 billion
AARTIDRUGS · Aarti Drugs Limited — ₹39 billion
4577 · Daito Pharmaceutical Co.,Ltd. — JPY 38 billion
GALD · Galderma Group AG — CHF 37 billion
SOLARA · Solara Active Pharma Sciences Limited — ₹36 billion
4595 · Mizuho Medy Co.,Ltd. — JPY 33 billion

← UNI All “U” companies UNIDT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.